The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 45 of the 50 references it cites were found in a registry or an index.
Abstract
Observational studies have indicated an inverse association between vitamin D levels and the risk of diabetes, yet evidence from population interventions remains inconsistent. PubMed, EMBASE, Cochrane Library and ClinicalTrials.gov were searched up to September 2017. Data from studies regarding serum 25(OH)D, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were pooled. Twenty studies (n = 2703) were included in the meta-analysis. Vitamin D supplementation resulted in a significant improvement in serum 25(OH)D levels (weighted mean difference (WMD) = 33.98; 95%CI: 24.60–43.37) and HOMA-IR (standardized mean difference (SMD) = −0.57; 95%CI: −1.09~−0.04), but not in other outcomes. However, preferred changes were observed in subgroups as follows: short-term (WMDFBG = −8.44; 95%CI: −12.72~−4.15), high dose (WMDFBG = −8.70; 95%CI: −12.96~−4.44), non-obese (SMDFasting insulin = −1.80; 95%CI: −2.66~−0.95), Middle Easterners (WMDFBG = −10.43; 95%CI: −14.80~−6.06), baseline vitamin D deficient individuals (WMDFBG = −5.77; 95%CI: −10.48~−1.05) and well-controlled HbA1c individuals (WMDFBG = −4.09; 95%CI: −15.44~7.27). Vitamin D supplementation was shown to increase serum 25(OH)D and reduce insulin resistance effectively. This effect was especially prominent when vitamin D was given in large doses and for a short period of time, and to patients who were non-obese, Middle Eastern, vitamin D deficient, or with optimal glycemic control at baseline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“The strength of the evidence was categorized as high, moderate, low or very low [19].”
BackgroundVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationHolick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,001
Vitamin D and type 2 diabetes: a systematic review
Mitri, J., Muraru, M. D., & Pittas, A. G. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.118 · Cited by 570
Research works printed but not linked: 1
- Li, 2016, Effects of Vitamin D Supplementation on Glycaemic Control, Insulin Resistance and β Cell Function in Type 2 Diabetes Mellitus: A Meta-analysis, Chin. J. Evid.-Based Med., 16, 1080
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging
Bruins, M. J., Van Dael, P., & Eggersdorfer, M. (2019) · Nutrients · doi:10.3390/nu11010085 · Cited by 223
“Changes in other parameters such as fasting blood glucose and hemoglobin A1c (HbA1c) were relatively small and did not achieve statistical significance [137].”
BackgroundArgano, C., Mirarchi, L., Amodeo, S., Orlando, V., Torres, A., & Corrao, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015485 · Cited by 204
“In another meta-analysis, vitamin D intake significantly decreased insulin resistance in people with T2DM [216].”
BackgroundDong, B., Zhou, Y., Wang, W., Scott, J., Kim, K., Sun, Z., Guo, Q., Lu, Y., Gonzales, N. M., Wu, H., et al. (2020) · Hepatology · doi:10.1002/hep.30937 · Cited by 180
“1572 and T2DM has been spurred in recent years, different patient cohorts have shown inconsistent effectiveness of vitamin D supplementation.(25,43,44) One challenge in targeting VDR is confirming the efficacy of vitamin D and its synthetic analogs, particularly because the local concentration of activated vitamin D i…”
BackgroundRebelos, E., Tentolouris, N., & Jude, E. (2023) · Drugs · doi:10.1007/s40265-023-01875-8 · Cited by 167
“, an index of insulin resistance) was improved [134].”
BackgroundVitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
Grant, W. B., Wimalawansa, S. J., Płudowski, P., & Cheng, R. Z. (2025) · Nutrients · doi:10.3390/nu17020277 · Cited by 185
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116
“…significant improvement in HOMA-IR (standardized mean difference = −0.57; 95% CI: −1.09 to −0.04), particularly when vitamin D was administered in large doses and for a short period of time to nonobese, vitamin D deficient patients, or to individuals with optimal glucose control at baseline [106].”
BackgroundInfluentialThe Effect of Diet and Lifestyle on the Course of Diabetic Retinopathy—A Review of the Literature
Bryl, A., Mrugacz, M., Falkowski, M., & Zorena, K. (2022) · Nutrients · doi:10.3390/nu14061252 · Cited by 112
López-Pedrosa, J. M., Camprubí-Robles, M., Rolo, G. G., Lopez-Gonzalez, A., García‐Almeida, J. M., Sanz‐París, A., & Rueda, R. (2024) · Nutrients · doi:10.3390/nu16010172 · Cited by 116
Nutritional and medical food therapies for diabetic retinopathy
Shi, C., Wang, P., Airen, S., Brown, C. J., Liu, Z., Townsend, J. H., Wang, J., & Jiang, H. (2020) · Eye and Vision · doi:10.1186/s40662-020-00199-y · Cited by 91
Self-citationFarahmand, M. A., Daneshzad, E., Fung, T. T., Zahidi, F., Muhammadi, M., Bellissimo, N., & Azadbakht, L. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01209-x · Cited by 97
Vitamin D deficiency in the aetiology of obesity‐related insulin resistance
Pramono, A., Jocken, J. W. E., & Blaak, E. E. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3146 · Cited by 73
“Perhaps ethnic/geographical location and genetic variations of vitamin D–related metabolism(106,107) may influence responses to, and benefits of, vitamin D supplementation.(104,108) Therefore, further evaluation of genetic determinants of vitamin D status among different ethnic/geographical groups and metabolic phenot…”
BackgroundWang, Y., Yang, S., Zhou, Q., Zhang, H., & Yi, B. (2019) · Kidney and Blood Pressure Research · doi:10.1159/000498838 · Cited by 60
Vitamin D: immune function, inflammation, infections and auto-immunity
Johnson, C. R., & Thacher, T. D. (2023) · Paediatrics and International Child Health · doi:10.1080/20469047.2023.2171759 · Cited by 77
“Meta-analysis of vitamin D supplementation on fasting glucose, glycated haemoglobin and insulin resistance overall showed little benefit [118,119]; however, certain subgroups — patients who were non-obese, Middle Eastern, vitamin D-deficient or with baseline optimal glycaemic control — experienced…”
BackgroundMarquina, C., Mousa, A., Scragg, R. K. R., & de Courten, B. V. (2018) · Obesity Reviews · doi:10.1111/obr.12793 · Cited by 67
“A meta-analysis of 20 RCTs in 2,703 patients showed no difference in HbA1c, but there was a significant reduction in HOMA-IR and fasting glucose following vitamin D supplementation only in vitamin Ddeficient patients, but not in those with sufficient or insufficient vitamin D status (74).”
MethodChen, W., Liu, L., & Hu, F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15941 · Cited by 89
“60 However, it showed no apparent effects on HbA1c and fasting insulin levels.”
Vitamin D: A magic bullet or a myth?
Reijven, P. L. M., & Soeters, P. B. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.12.028 · Cited by 58
Geng, T., Lu, Q., Wan, Z., Guo, J., Liu, L., Pan, A., & Liu, G. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003906 · Cited by 57
Fuentes-Barría, H., Aguilera-Eguía, R. A., Flores-Fernández, C., Angarita, L., Rojas-Gómez, D. M., Alarcón-Rivera, M., López-Soto, O., & Maureira-Sánchez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052153 · Cited by 245
Golmohammadi, M., Ayremlou, P., & Zarrin, R. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000596 · Cited by 51
Efficacy of Dietary and Supplementation Interventions for Individuals with Type 2 Diabetes
Lewgood, J., Oliveira, B., Korzepa, M., Forbes, S. C., Little, J. P., Breen, L., Bailie, R., & Candow, D. G. (2021) · Nutrients · doi:10.3390/nu13072378 · Cited by 57
Vitamin D is an endogenous partial agonist of the transient receptor potential vanilloid 1 channel
Long, W., Fatehi, M., Soni, S., Panigrahi, R. R., Philippaert, K., Yu, Y., Kelly, R. G., Boonen, B., Barr, A., Golec, D. P., et al. (2020) · The Journal of Physiology · doi:10.1113/jp279961 · Cited by 46
“One potential candidate is vitamin D, as its deficiency (Holick, 2007) is similarly associated with metabolic disorders (Grammatiki et al. 2017; Li et al. 2018), nociceptive disorders (Yong et al.”
BackgroundPark, C. Y., Shin, S., & Han, S. N. (2024) · Nutrients · doi:10.3390/nu16183185 · Cited by 53
“Li et al. [50] discovered that these effects were particularly prominent in subgroups receiving short-term, high-dose vitamin D as well as among Middle Eastern participants and those with baseline vitamin D deficiency, with a decrease in fasting plasma glucose levels being shown.”
BackgroundObesity-Induced Vitamin D Deficiency Contributes to Lung Fibrosis and Airway Hyperresponsiveness
Han, H., Chung, S. I., Park, H. J., Oh, E. Y., Kim, S., Park, K. H., Lee, J.-H., & Park, J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0086oc · Cited by 42
Krisnamurti, D. G. B., Louisa, M., Poerwaningsih, E. H., Tarigan, T. J. E., Soetikno, V., Wibowo, H., & Nugroho, C. M. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1089298 · Cited by 54
Pitaya as a New Alternative Crop for Iberian Peninsula: Biology and Edaphoclimatic Requirements
Trindade, A. R., Paiva, P. E. B., Lacerda, V. R., Marques, N. T., Neto, L., & Duarte, A. (2023) · Plants · doi:10.3390/plants12183212 · Cited by 44
Mavar, M., Sorić, T., Bagarić, E., Sarić, A., & Sarić, M. M. (2024) · Nutrients · doi:10.3390/nu16081176 · Cited by 64
“According to the results of a systematic review performed by Li et al. [125], vitamin D supplementation positively influenced serum levels of 25(OH)D and reduced insulin resistance; however, without an impact on HbA1c, fasting glucose level, and fasting insulin level.”
ResultPramono, A., Jocken, J. W. E., Blaak, E. E., & van Baak, M. A. (2020) · Diabetes Care · doi:10.2337/dc19-2265 · Cited by 53
“It also should be noted that the results could be affected by other factors such as variation in age, season (19), and ethnicity (23) as well as tissue-specific metabolism and insulin resistance (60).”
BackgroundOstadmohammadi, V., Milajerdi, A., Ghayour‐Mobarhan, M., Ferns, G. A., Taghizadeh, M., Badehnoosh, B., Mirzaei, H., & Asemi, Z. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190308152943 · Cited by 45
Is there an association between vitamin D and diabetic foot disease? A meta‐analysis
Yammine, K., Hayek, F., & Assi, C. (2019) · Wound Repair and Regeneration · doi:10.1111/wrr.12762 · Cited by 43
NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways
Zhang, Z., Moon, R., Thorne, J. L., & Moore, J. B. (2021) · Nutrition Research Reviews · doi:10.1017/s095442242100038x · Cited by 47
“control in people with prediabetes and type 2 diabetes(138,139),”
Johny, E., Jala, A., Nath, B., Alam, M. J., Kuladhipati, I., Das, R., Borkar, R. M., & Adela, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869591 · Cited by 43
Qiang, T., Wang, J., Jiang, L., & Xiong, K. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119359 · Cited by 39
Vitamin D and major chronic diseases
Zhao, S., Qian, F., Wan, Z., Chen, X., Pan, A., & Liu, G. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.018 · Cited by 50
Qi, K.-J., Zhao, Z.-T., Zhang, W., & Yang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033026 · Cited by 75
Musazadeh, V., Kavyani, Z., Mirhosseini, N. Z., Dehghan, P., & Vajdi, M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01010-3 · Cited by 47
“…Both /NR Diabetic Adults NR NR Mirhosseini et al. 2018 Canada 3062 Both /49 Prediabetics 4030 NR Milajerdi et al. 2019 Iran 214 Both /50 CKD 2683 8 Li et al. 2018 China 2104 Both /56 T2DM 4991 18 Lee et al. 2017 USA 2295 Both/54 T2DM 3410 40 Łagowska et al. 2018 Poland 458 Women/26 PCOS 4614…”
BackgroundYuan, S., Jiang, X., Michaëlsson, K., & Larsson, S. C. (2019) · Diabetes Care · doi:10.2337/dc19-1247 · Cited by 38
Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?
Li, L., Liu, S., & Yu, J. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820958329 · Cited by 42
Hou, Y., Lu, C., Zheng, C., Chen, R., Lin, Y., Liu, W.-C., Yen, T., Chen, R., & Lu, K. (2019) · Nutrients · doi:10.3390/nu11010152 · Cited by 38
“Hypovitaminosis is associated with more advanced cardiovascular disease because of insulin resistance [69] and activation of the renin–angiotensin–aldosterone system [70].”
BackgroundEffect of Vitamin D Supplementation on Glycemic Control in Prediabetes: A Meta-Analysis
Zhang, Y., Xue, Y., Zhang, D., Liu, Y., Xu, Z., Gao, J., Li, W., & Li, X. (2021) · Nutrients · doi:10.3390/nu13124464 · Cited by 37
“Previous studies [50,51] found that the protective effects of vitamin D supplementation on T2DM were primarily generated by intervention periods of less than three months.”
ResultSelf-citationLee, M. (2025) · Nutrients · doi:10.3390/nu17030586 · Cited by 49
“Sub-group analyses showed that greater effects in nonobese than obese subjects [121,122,125], given high dosage (>2000 IU/d), individuals with vitamin D deficiency at baseline [114,123], or in patients who had diabetes 10 years or with an age 60 years old [124].”
Lerchbaum, E., Trummer, C., Theiler-Schwetz, V., Kollmann, M., Wölfler, M., Pilz, S., & Obermayer-Pietsch, B. (2019) · Nutrients · doi:10.3390/nu11081894 · Cited by 29
“In contrast, a recent meta-analysis found a significant positive effect on insulin resistance among subjects with type 2 diabetes mellitus [16].”
ResultVitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome
Bari, F. D., Catalano, A., Bellone, F., Martino, G., & Benvenga, S. (2021) · Metabolites · doi:10.3390/metabo11020116 · Cited by 33
Galușca, D., Popoviciu, M. S., Babeş, E. E., Vidican, M., Zaha, A. A., Babeş, V. V., Jurcă, A. D., Zaha, D. C., & Bodog, F. D. (2022) · Medicina · doi:10.3390/medicina58020194 · Cited by 37
“04), but there were no other major influences on the outcome [55].”
BackgroundHu, Z., Zhi, X., Li, J., Li, B., Wang, J., Zhu, J., & Zhang, Z. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106198 · Cited by 42
Asbaghi, O., Khosroshahi, M. Z., Kashkooli, S., & Abbasnezhad, A. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0887-0205 · Cited by 212
“Recently, a systematic review and meta-analysis indicated that daily doses of vitamin D ≥ 2000 IU/day had a positive impact on glycemic control [43].”
BackgroundVasdeki, D., Tsamos, G., Dimakakos, E. P., Patriarcheas, V., Koufakis, T., Kotsa, K., Cholewka, A., & Stanek, A. (2024) · Nutrients · doi:10.3390/nu16213651 · Cited by 36
“A meta-analysis conducted by Krul-Poel and colleagues revealed no significant change in HbA1c levels following VD supplementation compared to a placebo, a result echoed by Li [81,82].”
MethodResultLei, X., Zhou, Q., Wang, Y., Fu, S., Li, Z., & Chen, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-39469-9 · Cited by 227
Milajerdi, A., Ostadmohammadi, V., Amirjani, S., Kolahdooz, F., & Asemi, Z. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02236-9 · Cited by 24
The role of micronutrients on the treatment of diabetes
Younes, S. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200238 · Cited by 38
Hu, Z., Tao, S., Liu, H., Pan, G.-T., Li, B., & Zhang, Z. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8289741 · Cited by 24
“Recent studies find that vitamin D3 supplementation improved insulin secretion in diabetic patients [12] and show beneficial effects in diabetic patients with poor glycemic control [13].”
Talari, H. R., Najafi, V., Raygan, F., Mirhosseini, N. Z., Ostadmohammadi, V., Amirani, E., Taghizadeh, M., Hajijafari, M., Shafabakhash, R., & Asemi, Z. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001132 · Cited by 25
“Moreover, the results of meta-analysis studies revealed that vitamin D supplementation decreased insulin resistance(19)”
MethodResultDoes Vitamin D Have a Role in Diabetes?
Abugoukh, T. M., Sharaby, A. A., Elshaikh, A. O., Joda, M., Madni, A., Ahmed, I., Abdalla, R. S., Ahmed, K., Elazrag, S. E., & Abdelrahman, N. G. (2022) · Cureus · doi:10.7759/cureus.30432 · Cited by 56
Nikooyeh, B., Zargaraan, A., Kalayi, A., Shariátzadeh, N., Zahedirad, M., Jamali, A., Khazraie, M., Hollis, B. W., & Neyestani, T. R. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02103-4 · Cited by 23
Magyarországi konszenzusajánlás a D-vitamin szerepéről a betegségek megelőzésében és kezelésében
Takács, I., Dank, M., Majnik, J., Nagy, G., Szabó, A., Szabó, B., Szekanecz, Z., Sziller, I., Toldy, E., Tislér, A., et al. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32463 · Cited by 34
“Ugyanakkor metaanalízisek igazolták a fordított arányosságot a D-vitamin-ellátottság és a T2DM kockázata között, és bizonyították a D-vitaminpótlás előnyös hatását a vércukorértékekre és a hemoglobin-A1c-re [54, 55].”
Vitamin D and cardiovascular disease risk. A literature overview
Cortese, F., Costantino, M. F., Luzi, G., Marino, S. D., Giordano, P., & Monitillo, F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07373-6 · Cited by 25
Mechanisms Suggesting a Relationship between Vitamin D and Erectile Dysfunction: An Overview
Crafa, A., Cannarella, R., Barbagallo, F., Leanza, C., Palazzolo, R., Flores, H. A., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2023) · Biomolecules · doi:10.3390/biom13060930 · Cited by 24
“They also noted that these effects were most evident with a high dose of vitamin D over a short period in normalweight, Middle Eastern, and VDD patients or those with optimal glycemic control at baseline [78].”
BackgroundInfluentialTang, Y. C., Huang, Y., Luo, L., Xu, M., Deng, D., Fang, Z., Zhao, X., & Chen, M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01002-3 · Cited by 20
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome
Zanoli, L., Pino, A. D., Terranova, V., Marca, S. D., Pisano, M., Quattro, R. D., Ferrara, V., Scicali, R., Rabuazzo, A. M., Fatuzzo, P. M., et al. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.08.003 · Cited by 19
“It is known that physical activity can potentially affect both inflammation and arterial stiffening, whereas Vitamin D may play a pivotal role in modulating insulin resistance [29] and is inversely associated with increased arterial stiffness [30].”
BackgroundChen, L., Dong, Y., Bhagatwala, J., Raed, A., Huang, Y., & Zhu, H. (2020) · Nutrients · doi:10.3390/nu12040981 · Cited by 20
“Studies suggest that vitamin D supplementation may improve glycemic controls and insulin sensitivity [11,12].”
BackgroundGirard, E., Nacher, M., Bukasa-Kakamba, J., Fahrasmane, A., Adenis, A. A., Massicard, M., Alsibai, K. D., de Toffol, B., Bekima, R., Thelusme, L., et al. (2021) · Nutrients · doi:10.3390/nu13124302 · Cited by 19
“In particular, we noted a decrease in insulin resistance in diabetic patients treated with VD, and thus an improvement in glycemic control [34,35].”
BackgroundSantos, H. O., Martins, C. E. C., Forbes, S. C., & Delpino, F. M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.03.016 · Cited by 21
Thani, M. A., Sadoun, E., Sofroniou, A., Jayyousi, A., Baagar, K. A. M., Al-Hamaq, A. O. A. A., Vinodson, B., Akram, H., Bhatti, Z. S., Nasser, H. S., et al. (2019) · BMC Nutrition · doi:10.1186/s40795-019-0311-x · Cited by 20
Fong, C., Alesi, S., Mousa, A., Moran, L., Deed, G., Grant, S., Tapia, K. A., & Ee, C. (2022) · Nutrients · doi:10.3390/nu14112295 · Cited by 30
“Observational studies have demonstrated an association between vitamin D deficiency and the onset and progression of T2D [67], and it has been suggested that vitamin D supplementation exerts a hypoglycaemic effect by stimulating pancreatic beta cell function [68].”
BackgroundIqhrammullah, M., Duta, T. F., Alina, M., Qanita, I., Naufal, M. A., Henira, N., Tsurayya, G., Fathima, R., Rizki, A. Y. K., & Amirah, S. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100175 · Cited by 17
Effects of Vitamin D Deficiency on Sepsis
Seok, H., Kim, J., Choi, W. S., & Park, D. W. (2023) · Nutrients · doi:10.3390/nu15204309 · Cited by 19
“Recent studies have focused on the role of vitamin D in cell proliferation and differentiation in muscles and the immune system and found an association between vitamin D deficiency and cancer, infectious diseases, and autoimmune diseases, as well as cardiovascular diseases and diabetes [13,14].”
BackgroundProtective Role of Vitamin D Therapy in Diabetes Mellitus Type II
Zakhary, C. M., Rushdi, H., Hamdan, J. A., Youssef, K. N., Khan, A., Abdalla, M. A., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.17317 · Cited by 25
Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Ping, W.-X., Hu, S., Su, J., & Ouyang, S. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i3.361 · Cited by 25
Vitamin D Deficiency in Elderly With Diabetes Mellitus Type 2: A Review
Papaioannou, I., Πανταζίδου, Γ., Kokkalis, Z. T., Georgopoulos, N. A., & Jelastopulu, E. (2021) · Cureus · doi:10.7759/cureus.12506 · Cited by 16
TRPV1 channels as a newly identified target for vitamin D
Long, W., Johnson, J., Kalyaanamoorthy, S., & Light, P. E. (2021) · Channels · doi:10.1080/19336950.2021.1905248 · Cited by 16
Mohammed, A. A., Abo–Elmatty, D. M., Abdel-Azeem, R., Raafat, K., Hussein, M., El-Ansary, A. R., Hafez, W., Hassan, H. A., Nassar, N. A., Selim, N. M., et al. (2023) · Healthcare · doi:10.3390/healthcare11040485 · Cited by 15
“A recent meta-analysis confirmed the efficacy of vitamin D supplementation on the reduction of insulin resistance when given in large doses for shorter periods, especially in those with vitamin D deficiency and optimal glycemic control at baseline [59].”
MethodVitamin D status and its management for achieving optimal health benefits in the elderly
Boucher, B. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1533401 · Cited by 17
“This effect is now confirmed by large meta-analyses of two RCTs, one that showed reductions in IR in T2DM patients with increased VitD status, and the other showing reduced T2DM risk in initially normoglycemic subjects given VitD (2000 IU/day), especially when VitD was given without calcium supplements, those risk red…”
ResultJohnson, B. V. B., Milstead, M., Kreider, R., & Jones, R. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100209 · Cited by 27
“In human studies, a meta-analysis with 20 RCTs in patients with type 2 diabetes found vitamin D supplementation significantly improved serum 25(OH)D levels and homeostasis model assessment of insulin resistance [36].”
Luo, W., Dong, X., Ye, H., Zhao, Q.-S., Zhang, Q., Guo, W., Liu, H., & Xu, F. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i12.4685 · Cited by 17
Nutrients and Natural Substances for Hypoglycemic Effects and Management in Diabetic Retinopathy
Cappellani, F., Foti, R., Malaguarnera, G., D’Esposito, F., Musumeci, C., Rapisarda, L., Tognetto, D., Gagliano, C., & Zeppieri, M. (2025) · Nutrients · doi:10.3390/nu17071207 · Cited by 14
“The natural compounds could have a preventive role through the improvement of glycemic control during the initial phases of DR progression [8–13].”
Qorbani, M., Zarei, M., Moradi, Y., Appannah, G., Djalainia, S., Pourrostami, K., Ejtahed, H., Mahdavi‐Gorabi, A., Naderali, E. K., & Khazdouz, M. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00859-0 · Cited by 13
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
Xie, X., Bai, G., Liu, H., Zhang, L., He, Y., Qiang, D., & Zou, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s301352 · Cited by 13
Dietary recommendations for persons with type 2 diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kleinridders, A., Kronsbein, P., Müssig, K., Nussbaumer, H., Pfeiffer, A. F. H., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-5095 · Cited by 13
Yin, X., Chen, J., Huang, X.-J., Lai, J.-H., Huang, C., Wang, Y., Li, N., Huang, W.-C., & Guo, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.883904 · Cited by 18
Xu, J., Zhang, X., Tong, W.-T., Ying, T., & Liu, K.-Q. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1108477 · Cited by 15
Archontogeorgis, K., Παπάνας, Ν., Rizos, E. C., Nena, E., Zissimopoulos, A., Tsigalou, C., Voulgaris, A., Mikhailidis, D. P., Elisaf, M., Froudarakis, Μ. E., et al. (2019) · Medicina · doi:10.3390/medicina55050174 · Cited by 13
“Additionally, recent meta-analyses have shown that Vit D supplementation reduces insulin resistance in selected patient series [30,31].”
Effects of Maternal Vitamin D Supplementation on Childhood Health
Svensson, N. S., Volqvartz, T., Vestergaard, A. L., Vestergaard, E. T., Larsen, A., & Bor, P. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf034 · Cited by 13
Hua, R., Lam, C. S., Chu, N. H. S., Yang, A., Chow, E., & Cheung, Y. T. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00753-0 · Cited by 13
Vitamin D supplementation modulates glycated hemoglobin (HBA1c) in diabetes mellitus
Akhter, A., Alouffi, S., Shahab, U., Akasha, R., Fazal-Ur-Rehman, M., Ghoniem, M. E., Ahmad, N., Kaur, K., Pandey, R. P., Alshammari, A. M., et al. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109911 · Cited by 14
Vitamin D and the NLRP3 Inflammasome
Tunbridge, M. J., & Gois, P. H. F. (2020) · Applied Sciences · doi:10.3390/app10238462 · Cited by 14
“However, two meta-analyses have suggested the benefit of VD supplementation on measures of glycaemic control and insulin resistance, albeit with some substantial heterogeneity between studies [71,72].”
BackgroundSalarinia, M., Azizi, M., Tahmasebi, W., & Khalvandi, H. (2023) · Science & Sports · doi:10.1016/j.scispo.2022.04.008 · Cited by 11
Vitamin D and risk of developing type 2 diabetes in the SUN project: a prospective cohort study
Valer-Martínez, A., Sayón-Orea, C., Martínez, J. A., Basterra-Gortari, F. J., Martínez‐González, M. Á., & Bes‐Rastrollo, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02324-3 · Cited by 14
“In addition, Li X et al. evinced a partial reduction of insulin resistance compared with placebo in patients diagnosed with T2D [20].”
BackgroundEmpfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Pfeiffer, A. F. H., Simon, M., Tombek, A., et al. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1543-1293 · Cited by 10
Talari, H. R., Najafi, V., Raygan, F., Mirhosseini, N. Z., Ostadmohammadi, V., Amirani, E., Taghizadeh, M., Hajijafari, M., Shafabakhsh, R., & Asemi, Z. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001971 · Cited by 10
Diabetes and vitamin D: The effect of insulin sensitivity and gut microbial health
Daley, D. K., & Myrie, S. B. (2024) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2024.04.001 · Cited by 16
Chinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
Cheng, L., Lv, C., Xue, L., Zhang, C., Wang, L., Wang, X., Chen, S., Li, X., Feng, W., Xie, H., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1462535 · Cited by 196
Self-citationMolani‐Gol, R., Rafraf, M., & Safari, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00994-1 · Cited by 11
“A meta-analysis also showed that vitamin D supplementation in T2DM patients showed more improvement in glycemic markers among non-obese individuals than obese individuals [68].”
Tang, W., Chen, L., Ma, W., Liu, G., Chen, D., Wang, C., Gao, Y., & Ran, X. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13917 · Cited by 15
Liu, Z., Sun, H., Chen, Y., He, J., Zhu, L., Yang, B., & Zhao, W. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01264-5 · Cited by 12
“Notably, a substantial impact was observed when high doses of vitamin D were administered for a brief period, specifically targeting non-obese individuals of Middle Eastern descent who exhibited vitamin D deficiency or patients with optimal glycemic control at the outset [36].”
BackgroundHoseini, Z., Behpour, N., & Hoseini, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-57023-z · Cited by 10
“Previous studies have investigated the effects of both AT 17 and Vit D supplementation 18 on glycemic control, insulin action, and cardiorespiratory fitness in individuals with T2DM, reporting contradictory results.”
Polycystic ovary syndrome and vitamin D serum levels
Ćetković, N. B., Pellicano, R., Bjelica, A., & Abenavoli, L. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02887-0 · Cited by 9
Herrera, M. T., Juárez, E., Guzmán‐Beltrán, S., Torres, M., Luna-Morales, V. A., Villalana-Alvarez, L. D., & González, Y. (2022) · Biomolecules · doi:10.3390/biom12020268 · Cited by 11
“Low levels of 25(OH)D3 increase the risk of type 2 diabetes mellitus (T2DM) [14], and in T2DM patients, whose vitamin D levels are low, vitamin D supplementation significantly increases its serum levels and reduces insulin resistance [15].”
BackgroundVitamin D deficiency and diabetic retinopathy risk
Navaei, S., Nazemi, S., Emamian, M. H., Hashemi, H., & Fotouhi, A. (2023) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2023.01.024 · Cited by 9
Metadata
- Authors
- Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y.
- Affiliations
- Peking University (CN)
- Corresponding author
- Zhang, Yumei
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-03-19
- Volume
- 10
- Issue
- 3
- Pages
- 375
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5872793
- OpenAlex
- W2789558207
- Cited by
- 266
- References
- 50
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 44 · 2023: 48 · 2022: 51 · 2021: 35 · 2020: 18 · 2019: 23 · 2018: 6
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81573429, 2017YFD0400602)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- vitamin D supplementation, type 2 diabetes, glycemic control, insulin resistance, HOMA-IR, serum 25-hydroxyvitamin D, fasting blood glucose, HbA1c, fasting insulin, vitamin D deficiency, dose and duration effects, obesity, Middle Eastern populations
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin Resistance, Male, Middle Aged, Vitamin D, Vitamin D Deficiency, Biomarkers, Treatment Outcome, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.